US Stock Market Closed

Dashboard

Abbott Laboratories (ABT)

bolt HIT FAIR VALUE

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

S

Analyst Opinion

B

Leverage & Liquidity

B

Fundamental Variables

H

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

CEO

Robert B. Ford

Employees

107,000

Industry

Diversified Medical Devices and Instruments

Sector

Healthcare

Headquarters

Abbott Park

Exchange

New York Stock Exchange

Summary Stats

Market Cap

186B

Revenue

45B

Net Income

7.89B

EPS

$4.45

Price-to-Earnings

24.04

Price-to-Book

5.23

Debt-to-Equity

1.04

News

Analyst Ratings

Price targets projected by 16 analysts

High

$130.00

Average

$120.31

Low

$107.00

Ratings calculated by 21 analysts

Buy

16

Hold

3

Sell

2

Last Dividend

Amount

$0.47

Dividend Date

Frequency

quarterly

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Above by $0.21

Actual

$1.15 +22.3%

Consensus

0.94

Report Date

Year Ago

1.4

Year Ago Change %

Down 17%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites